Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/88077
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer |
| Author: | Deenen, M. Tol, J. Burylo, A. Doodeman, V. de Boer, A. Vincent, A. Guchelaar, H. Smits, P. Beijnen, J. Punt, C. Schellens, J. Cats, A. |
| Citation: | Clinical Cancer Research, 2011; 17(10):3455-3468 |
| Publisher: | American Association for Cancer Research |
| Issue Date: | 2011 |
| ISSN: | 1078-0432 1557-3265 |
| Statement of Responsibility: | Maarten J. Deenen, Jolien Tol, Artur M Burylo, Valerie D. Doodeman, Anthonius de Boer, Andrew Vincent, Henk-Jan Guchelaar, Paul H.M. Smits, Jos H. Beijnen, Cornelis J.A. Punt, Jan H.M. Schellens and Annemieke Cats |
| Abstract: | Abstract not available |
| Keywords: | Humans Carcinoma Colorectal Neoplasms Disease Progression Fluorouracil Dihydrouracil Dehydrogenase (NADP) Deoxycytidine Antimetabolites, Antineoplastic Treatment Outcome Case-Control Studies Retrospective Studies Cohort Studies Dose-Response Relationship, Drug Haplotypes Polymorphism, Single Nucleotide Adult Aged Aged, 80 and over Middle Aged Female Male Randomized Controlled Trials as Topic Clinical Trials, Phase III as Topic Biomarkers, Pharmacological Drug-Related Side Effects and Adverse Reactions Biomarkers, Tumor Capecitabine |
| Description: | Note: Supplementary data for this article are available at Clinical Cancer Research Online (http://clincancerres.aacrjournals.org/). |
| Rights: | ©2011 American Association for Cancer Research. |
| DOI: | 10.1158/1078-0432.CCR-10-2209 |
| Published version: | http://dx.doi.org/10.1158/1078-0432.ccr-10-2209 |
| Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.